KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Asset Utilization Ratio (2016 - 2025)

Teva Pharmaceutical Industries' Asset Utilization Ratio history spans 9 years, with the latest figure at 0.43 for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio rose 14.1% year-over-year to 0.43, compared with a TTM value of 0.43 through Dec 2025, up 14.1%, and an annual FY2025 reading of 0.43, up 7.87% over the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.43 at Teva Pharmaceutical Industries, up from 0.39 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.43 in Q4 2025, with the low at 0.33 in Q1 2021.
  • Average Asset Utilization Ratio over 5 years is 0.36, with a median of 0.35 recorded in 2023.
  • Biggest YoY gain for Asset Utilization Ratio was 14.1% in 2025; the steepest drop was 4.32% in 2025.
  • Tracing TEVA's Asset Utilization Ratio over 5 years: stood at 0.33 in 2021, then rose by 1.72% to 0.34 in 2022, then grew by 9.5% to 0.37 in 2023, then increased by 1.33% to 0.38 in 2024, then increased by 14.1% to 0.43 in 2025.
  • Per Business Quant, the three most recent readings for TEVA's Asset Utilization Ratio are 0.43 (Q4 2025), 0.39 (Q3 2025), and 0.39 (Q2 2025).